Role of edaravone as a treatment option for patients with amyotrophic lateral sclerosis

HE Cho, S Shukla - Pharmaceuticals, 2020 - mdpi.com
Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive
and fatal neurodegenerative disease that leads to a loss of muscle control due to nerve cells …

Drug discovery and amyotrophic lateral sclerosis: Emerging challenges and therapeutic opportunities

P Soares, C Silva, D Chavarria, FSG Silva… - Ageing Research …, 2023 - Elsevier
Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of upper and lower
motor neurons (MNs) leading to paralysis and, ultimately, death by respiratory failure 3–5 …

Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: evaluating the impact of treatment crossover on outcomes

S Paganoni, C Watkins, M Cawson, S Hendrix… - Muscle & …, 2022 - Wiley Online Library
Abstract Introduction/Aims Trials incorporating placebo‐to‐active treatment crossover are
encouraged in fatal conditions like amyotrophic lateral sclerosis (ALS) but may …

[HTML][HTML] Nicotinamide riboside enhances mitochondrial proteostasis and adult neurogenesis through activation of mitochondrial unfolded protein response signaling …

Q Zhou, L Zhu, W Qiu, Y Liu, F Yang… - International Journal of …, 2020 - ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) is caused by the progressive degeneration of motor
neurons in the spinal cord, the brain stem, and the motor cortex. So far, there is still a lack of …

Effects of the edaravone, a drug approved for the treatment of amyotrophic lateral sclerosis, on mitochondrial function and neuroprotection

SJ Cha, K Kim - Antioxidants, 2022 - mdpi.com
Edaravone, the first known free radical scavenger, has demonstrated cellular protective
properties in animals and humans. Owing to its antioxidant activity, edaravone modulates …

Cannabinoids, endocannabinoids, and synthetic cannabimimetic molecules in neuromuscular disorders

FA Iannotti - International Journal of Molecular Sciences, 2023 - mdpi.com
Neuromuscular disorders (NMDs) encompass a large heterogeneous group of hereditary
and acquired diseases primarily affecting motor neurons, peripheral nerves, and the skeletal …

Oxidative stress: the lowest common denominator of multiple diseases

V Matschke, C Theiss, J Matschke - Neural regeneration research, 2019 - journals.lww.com
Oxygen is essential to the human life and life of all aerobic organisms. The complete
oxidation of nutrients for the biological energy supply is one of the most important …

Quality of life and functional independence in amyotrophic lateral sclerosis: A systematic review

JPR Silva, JBS Júnior, EL Dos Santos… - Neuroscience & …, 2020 - Elsevier
Abstract Amyotrophic Lateral Sclerosis (ALS) leads to functional capacity decline,
generating great impact in quality of life. Quality of life is directly related to physical integrity …

The dual face of glutamate: from a neurotoxin to a potential survival factor—metabolic implications in health and disease

S Magi, S Piccirillo, S Amoroso - Cellular and Molecular Life Sciences, 2019 - Springer
Glutamate is the major excitatory neurotransmitter in the central nervous system. Beyond this
function, glutamate also plays a key role in intermediary metabolism in all organs and …

Identification of regulatory factors and prognostic markers in amyotrophic lateral sclerosis

H Sun, M Li, Y Ji, J Zhu, Z Chen, L Zhang, C Deng… - Antioxidants, 2022 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by
the progressive degeneration of motor neurons, leading to muscle atrophy, paralysis and …